Unum Therapeutics Inc.·4

Apr 11, 4:39 PM ET

VASCONCELLES MICHAEL 4

4 · Unum Therapeutics Inc. · Filed Apr 11, 2019

Insider Transaction Report

Form 4
Period: 2019-03-01
VASCONCELLES MICHAEL
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-03-01+61,90061,900 total
    Exercise: $4.36Exp: 2029-03-01Common Stock (61,900 underlying)
Footnotes (1)
  • [F1]25% of the shares vests on March 1, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Persons continuous service with the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION